Angiotensin II and TGF- ? in Progression of Fibrotic Renal Disease: Beyond Hemodynamics W. A. BORDER

Short-term effects of dapagliflozin on biomarkers of bone and mineral metabolism in patients with diabetic kidney disease: A prospective observational study Tugba Islek, Safak Mirioglu, Meltem Gursu, Rumeyza Kazancioglu, Metin Demirel, Sahabettin Selek, Omer Celal Elcioglu

FGF23 and mineral metabolism, implications in CKD-MBD Mariano Rodríguez, Ignacio López, Juan Muñoz, Escolástico Aguilera-Tejero, Yolanda Almaden